Gastric cancer is the fifth most common cancer and third leading cause of cancer deaths worldwide, with half of these occurring in Eastern Asia [1]. There are two major classification systems currently used, the Japanese classification and the system developed jointly by the American Joint Committee on Cancer (AJCC) and the Union for International Cancer Control (UICC). The Japanese classificat...

Gastric cancer is a common malignancy and cause of mortality. The aim of this study was to evaluate the accuracy of magnetic resonance imaging (MRI) and endoscopic ultrasound (EUS) detection in preoperative clinical T/N staging in gastric cancer. Thirty-eight patients diagnosed with gastric cancer by gastroscopy and pathological examination were included in the study. All 38 patients underwent ...

Background: The optimal nodal staging scheme for gastric cancer remains unsettled. We compared the prognostic performances of the metastatic lymph node, lymph node ratio, and log odds of metastatic lymph nodes based on nomograms among 801 patients with D2-resected gastric cancer treated with adjuvant chemotherapy. Methods: When assessed as a continuous covariate, each nodal staging variable was...

background: gastric cancer is the leading cause of cancer deaths in iran. treatment for gastric adenocarcinoma varies worldwide. the aim of this study is to evaluate char- acteristics and survival rate of gastric and gastroesophageal junction adenocarcinoma in yazd, iran. methods: this study was conducted on 53 patients with gastric or gastroesophageal junction adenocarcioma who referred to sha...

BACKGROUND Gastric cancer with cancer cells on peritoneal cytology has very poor prognosis because of the existence of simultaneous peritoneal metastasis. Here we performed a dose-escalation study of intraperitoneal docetaxel (DTX) combined with S-1 to determine the maximum-tolerated dose (MTD) and recommended dose (RD) in gastric cancer with peritoneal dissemination. PATIENTS AND METHODS Twe...

BACKGROUND & OBJECTIVES Gastric cancer is the fourth most common cancer and the second leading cause of cancer-related deaths after lung carcinoma. The aim of this study was to understand the difference in clinicopathological behaviours and prognosis of gastric cancer in patients from China and Japan. METHODS Paraffin-fixed tissue samples of gastric cancer were collected retrospectively from ...

Gastric cancer is one of the most aggressive malignancies. Although there has been a slight increase in overall survival due to inclusion targeted medications standard chemotherapeutic treatment paradigm, prognosis remains poor. New evidence suggests that certain molecular and histopathologic tumor characteristics, as well staging, may also influence patients’ prognosis. Indeed, two detailed ge...

Despite a decrease in incidence, gastric cancer continues to be the third leading cause of cancer-related death worldwide.[1] For localized disease, surgery offers the best chance for cure. Despite surgery with curative intent, however, many patients experience recurrences, leading to dismal outcomes. With the goal of improving survival, neoadjuvant and adjuvant therapies have emerged. However,...

background: the presence of metastatic lymph nodes is the most important prognostic factor for gastric carcinoma; however, the optimal system for the accurate staging of lymph node metastasis for patients with gastric cancer remains controversial. this study was designed to compare five systems in relation to the n classification of gastric carcinoma. materials and methods: this multicentric hi...